Resultats de la cerca - Martin Filipits

Refinar resultats
  1. 1
    PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition

    PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition per Nandini Verma, Omer Keinan, Michael Selitrennik, Thomas Karn, Martin Filipits, Sima Lev

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR

    EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR per Anna Buder, Ulrike Setinek, Maximilian J. Hochmair, Sophia Schwab, Klaus Kirchbacher, Andrea Keck, Otto C. Burghuber, Robert Pirker, Martin Filipits

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia

    Expression of the Lung Resistance Protein Predicts Poor Outcome in De Novo Acute Myeloid Leukemia per Martin Filipits, Gudrun Pohl, Thomas Stranzl, Ralf W. Suchomel, Rik J. Scheper, Ulrich Jäger, Klaus Geißler, Klaus Lechner, Robert Pirker

    Publicat 1998
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Dual inhibition of EGFR and mTOR pathways in small cell lung cancer

    Dual inhibition of EGFR and mTOR pathways in small cell lung cancer per Katharina Schmid, Zsuzsanna Bagó-Horváth, Walter Berger, Andrea Haitel, Daniel Cejka, Johannes Werzowa, Martin Filipits, Beata Herberger, Hubert Hayden, Wolfgang Sieghart

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

    Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response... per Maximilian J. Hochmair, Anna Buder, Sophia Schwab, Otto C. Burghuber, Helmut Prosch, Wolfgang Hilbe, A. Cseh, Richard R. Fritz, Martin Filipits

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium <i>trans</i>-[Tetrachlorobis(1<i>H</i>-indazole)ruthenate(III)] (KP1019)

    X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium <i>trans</i>-[Tetrachlorobis(1<i>H</i>-indazole)ruthenate(III)] (K... per Alfred A. Hummer, Petra Heffeter, Walter Berger, Martin Filipits, David Batchelor, Gabriel E. Büchel, Michael A. Jakupec, Bernhard K. Keppler, Annette Rompel

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients

    O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients per Sabine Spiegl‐Kreinecker, Christine Pirker, Martin Filipits, Daniela Lötsch, Johanna Buchroithner, Josef Pichler, René Silye, Serge Weis, M. Micksche, Johannes Fischer, Walter Berger

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial

    The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer... per Florian Fitzal, Martin Filipits, M. Rudas, Richard Greil, Otto Dietze, H. Samonigg, Sigurd Lax, Walter Herz, Peter Dubsky, Rupert Bartsch, Ralf Kronenwett, Michael Gnant

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and Colorectal Cancer Study Group

    Clinical Role of Multidrug Resistance Protein 1 Expression in Chemotherapy Resistance in Early-Stage Breast Cancer: The Austrian Breast and Colorectal Cancer Study Group per Martin Filipits, Gudrun Pohl, Margaretha Rudas, Otto Dietze, Sigurd Lax, Renate Grill, Robert Pirker, Christoph Zielinski, H. Hausmaninger, E. Kubista, Hellmut Samonigg, R. Jakesz

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score

    Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimide... per Ivana Šestak, Jack Cuzick, Mitch Dowsett, Elena López‐Knowles, Martin Filipits, Peter Dubsky, J. Wayne Cowens, Sean Ferree, Carl Schaper, Christian Fesl, Michael Gnant

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

    Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblast... per Matthias Preusser, Anna S. Berghoff, Claudia Manzl, Martin Filipits, Andreas Weinhäusel, Walter Pulverer, Karin Dieckmann, Georg Widhalm, Adelheid Wöhrer, Engelbert Knosp, Christine Marosi, Johannes A. Hainfellner

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer

    High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer per Flora Zagouri, Zsuzsanna Bagó-Horváth, Fabian Rössler, Anita Brandstetter, Rupert Bartsch, C.A. Papadimitriou, Constantine Dimitrakakis, Alexandra Tsigginou, Irene Papaspyrou, Aris Giannos, Meletios Α. Dimopoulos, Martin Filipits

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

    Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement per Hatem A. Azim, Stefan Michiels, Flora Zagouri, Suzette Delaloge, Martin Filipits, M. Namer, P. Neven, W. Fraser Symmans, Alastair M. Thompson, Fabrice André, Sherene Loi, Charles Swanton

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer

    MutS Homologue 2 and the Long-term Benefit of Adjuvant Chemotherapy in Lung Cancer per Nermine S. Kamal, Jean‐Charles Soria, Jean Mendiboure, David Planchard, Ken A. Olaussen, Vanessa Rousseau, Helmut Popper, Robert Pirker, Pascale Bertrand, Ariane Dunant, Thierry Le Chevalier, Martin Filipits, Pierre Fouret

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis

    ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis per Gerold Bepler, Ken A. Olaussen, A.L. Vataire, Jean‐Charles Soria, Zhong Zheng, Ariane Dunant, Jean‐Pierre Pignon, Michael J. Schell, Pierre Fouret, Robert Pirker, Martin Filipits, Élisabeth Brambilla

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

    Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy per Margaretha Rudas, Martina Lehnert, Anh Tuan Huynh, R. Jakesz, Christian Singer, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, W. Kwasny, Renate Grill, M. Stierer, Michael Gnant, Martin Filipits

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2− Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only

    Prediction of Distant Recurrence Using EndoPredict Among Women with ER+, HER2− Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only per Martin Filipits, Peter Dubsky, Margaretha Rudas, Richard Greil, Marija Balić, Zsuzsanna Bagó-Horváth, Christian F. Singer, Dominik Hlauschek, Krystal Brown, Ryan Bernhisel, Ralf Kronenwett, Johnathan M. Lancaster, Florian Fitzal, Michael Gnant

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC

    Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC per Anna Buder, Maximilian J. Hochmair, Sophia Schwab, Tatjana Bundalo, Peter Schenk, Peter Errhalt, Romana Mikes, Gudrun Absenger, Kurt Patocka, Bernhard Baumgartner, Ulrike Setinek, Otto C. Burghuber, Helmut Prosch, Robert Pirker, Martin Filipits

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

    Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone per Ivana Šestak, Miguel Martín, Peter Dubsky, Ralf Kronenwett, Federico Rojo, Jack Cuzick, Martin Filipits, Amparo Ruı́z, William J. Gradishar, Hatem Soliman, Lee S. Schwartzberg, Richard Buus, Dominik Hlauschek, Álvaro Rodríguez-Lescure, Michael Gnant

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Cell Cycle Regulators and Outcome of Adjuvant Cisplatin-Based Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer: The International Adjuvant Lung Cancer Trial Biologic Program

    Cell Cycle Regulators and Outcome of Adjuvant Cisplatin-Based Chemotherapy in Completely Resected Non–Small-Cell Lung Cancer: The International Adjuvant Lung Cancer Trial Biologic... per Martin Filipits, Robert Pirker, Ariane Dunant, Sylvie Lantuéjoul, Katharina Schmid, Anh Tuan Huynh, Vincent Haddad, Fabrice André, Rolf A. Stahel, Jean‐Pierre Pignon, Jean‐Charles Soria, Helmut Popper, Thierry Le Chevalier, Élisabeth Brambilla

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: